Official UK procurement notice
BHRUT/Provision of Outsourcing Neuropathology Reporting Services UCLH
Authority: Barking, Havering and Redbridge University Hospitals NHS Trust (NHS & healthcare)
What is being bought
Published requirement descriptionProvision of Outsourcing Neuropathology Reporting Services from University College London Hospitals NHS Foundation Trust (UCLH)
Open work like this
This notice no longer takes bids · live search, filters set
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| supplier not publishedNeuro Pathology Reporting Services1 Apr 2027 – 31 Mar 2030 · up to 31 Mar 2031Extensions: Option to extend for 12 months · Options: An option to extend for 12 months | £768,000 | — | Standstill |
Procedure terms & legal framework
From the official record- Procedure method
- Direct award
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Unspecified in notice
- First published
- 18 Nov 2026, 09:21 GMT
- Last source update
- 18 Nov 2026, 09:21 GMT
- Authority reference
C169105- FTS notice number
2026/S 000-109118- Latest notice
- Transparency notice (UK5)
- Delivery area
- Not published
- Official registry OCID
ocds-h6vhtk-07be31Find a Tender
- Why no open competition
- Single Suppliers Technical Reasons
- Published justification
BHRUT intends to award a contract to University College London Hospitals NHS Foundation Trust (UCLH) for the provision of a Neuropathology Reporting Service.
BHRUT intends to award this contract using the Provider Selection Regime (PSR) Direct Award Process C. The service involves the referral of specimen samples by BHRUT to UCLH for specialist neuropathology testing, diagnostic interpretation, and reporting. The service includes the examination and reporting of brain biopsies, frozen sections and smears, cerebrospinal fluid specimens, temporal artery biopsies and vertebral biopsies.
UCLH provides access to a specialist neuropathology service with an established team of consultant neuropathologists and supporting laboratory staff, ensuring the capacity, expertise and resilience required to manage the volume and complexity of referrals received from BHRUT. The service supports timely and accurate diagnosis, access to specialist opinion and continuity of reporting for complex neurological and neurosurgical cases.
Justification for Direct Award under Procedure C
The Provider is the incumbent provider and has consistently delivered the service to a high standard, demonstrating strong clinical quality and supporting positive patient outcomes. The service is fully integrated into BHRUT's existing pathology and clinical pathways, with established referral and reporting processes that support effective collaboration between organisations and minimise disruption to patient care.
The existing arrangement has demonstrated value for money whilst maintaining access to a highly specialised diagnostic service. Retaining the incumbent provider avoids unnecessary transition costs and operational risks associated with changing provider and ensures the continued delivery of a sustainable and resilient service.
Continued access to UCLH's specialist neuropathology expertise supports equitable access for BHRUT patients to highly specialised diagnostic services that are not routinely available within a district general hospital setting. In addition, as an NHS provider, UCLH contributes to workforce development, education, training, and the wider advancement of specialist pathology services across the NHS.
The Provider has been evaluated against the five key criteria of the Provider Selection Regime and the assessment concluded that UCLH remains the most suitable provider to continue delivering the service.
This procurement falls outside the scope of application of the Public Contracts Regulations 2015 and the Procurement Act 2023. This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 and the Procurement Act 2023 do not apply to this award. This contract has not yet formally been awarded. This notice serves as an intention to award under the PSR.
The publication of this notice marks the start of the standstill period and closes on 17/12/26 Representations by providers must be made to the relevant authority by 16/12/2026 Any written representations should be made to [email protected] - Supplier Legal Name: [insert name]
- Company Registration Number: [insert number]
- Registered Office Address: [insert address]
Notice history
2 events · 1 release on Find a Tender · since 18 Nov 2026- Transparency notice published18 Nov 2026, 09:21 GMTUK5
- Contract signature expected26 Feb 2027, 23:59 GMTscheduled
Contracting authority & participating public bodies
Official documents & specifications (1)
Official links; attachments are not copiedNotices published for this procedure
- Transparency notice Transparency notice on Find a Tender